Posted on 2/14/19
Teva Pharmaceutical Industries Limited 2018 Q4 - Results - Earnings Call Slides
The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2018 Q4 earnings call. 138READ FULL ARTICLE HERE
Posted on 2/14/19
PTC Therapeutics Launches Fifth Annual STRIVE Grant Award Program for Duchenne Muscular Dystrophy
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the launch of the fifth annual STRIVE grant award program for Duchenne Muscular Dystrophy. The STRIVE Awards provide funds . . .
Posted on 2/14/19
Inovio Pharmaceuticals Announces Proposed Convertible Senior Notes Offering
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today its intention to offer, subject to market and other conditions, $65 million aggregate principal amount of convertible senior notes . . .
Posted on 2/13/19
Johnson & Johnson To Acquire Auris Health For $3.4B
Focused on creating the next frontier of surgery, Johnson & Johnson (NYSE: JNJ), today announced that Ethicon, Inc., entered into a definitive agreement to acquire Auris . . .
Posted on 2/13/19
Better Buy: Gilead Sciences vs. Pfizer
Neither Gilead Sciences (NASDAQ:GILD) nor Pfizer (NYSE:PFE) is expecting any sales growth this year. As a result, the market's already taken a swipe at both stocks, . . .
Posted on 2/12/19
Palatin Technologies Provides Corporate Update
Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide . . .
Posted on 2/12/19
ADMA Biologics Enters Into $72.5 Million Loan Facility with Perceptive Advisors
RAMSEY, N.J. and BOCA RATON, Fla., Feb. 12, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company . . .
Posted on 2/12/19
Avantor Begins Process For U.S. IPO
SummaryAvantor has filed to raise $100 million in an IPO, although the final amount may be much higher.The firm is the result of recent large mergers . . .
Posted on 2/11/19
Topcon Healthcare Solutions and Oculo Form Global Partnership
OAKLAND, N.J. & MELBOURNE, Australia--(BUSINESS WIRE)--Topcon Healthcare Solutions (THS), of Oakland, NJ, USA, a leading provider of software solutions for the eye care industry, and Oculo, . . .
Posted on 2/11/19
Is Celgene a Buy?
Celgene (NASDAQ:CELG) has a new spring in its step. The biotech stock performed dismally beginning in late 2017 after a major pipeline setback followed by a . . .
Posted on 2/8/19
Celldex Therapeutics Announces Reverse Stock Split
HAMPTON, N.J., Feb. 08, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced that its Board of Directors has approved a one-for-fifteen reverse stock split of . . .
Posted on 2/7/19
Medical Transcription Billing, Corp. Officially Changes Company Name to MTBC
SOMERSET, N.J, Feb. 07, 2019 (GLOBE NEWSWIRE) -- MTBC (NASDAQ:MTBC) (NASDAQ: MTBCP), a leading provider of cloud-based healthcare IT solutions and services, today announced the official . . .
Posted on 2/7/19
BioAegis Therapeutics Expands Phase 1b/2a Community-Acquired Pneumonia Study to the Republic of Georgia
MORRISTOWN, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. announced that patient enrollment is underway in a Phase 1b/2a study of recombinant plasma gelsolin . . .
Posted on 2/7/19
Tabula Rasa HealthCare Announces Proposed $250 Million Offering
MOORESTOWN, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) today announced its intention to offer, subject to market and other conditions, $250 . . .
Posted on 2/7/19
Science Center Just Gave $700K to Support Four Local Researchers
Four life sciences researchers at the University of Pennsylvania, University of Delaware, Children’s Hospital of
Posted on 2/6/19
Celgene/Bristol-Myers: Analyzing The News Of Starboard's Stake
Summary It was reported that Starboard has taken a stake in BMY. The market reaction indicates that investors believe Starboard will advocate against the Celgene acquisition. . . .
Posted on 2/6/19
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
RADNOR, Pa., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and . . .
Posted on 2/5/19
Better Buy: Johnson & Johnson vs. Merck & Co.
Investors of all stripes like Johnson & Johnson (NYSE:JNJ) because its careful assembly of related healthcare businesses has allowed the conglomerate to report steady earnings growth . . .
Posted on 2/5/19
Celgene Highlights What Bristol-Myers Squibb Is Getting
Celgene (NASDAQ:CELG) is on track to become part of Bristol-Myers Squibb (NYSE:BMY), but its earnings still matter for current shareholders because the acquisition includes a partial . . .
Posted on 2/5/19
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting . . .
Posted on 2/5/19
RxAnte Announces Partnership with Geisinger Health Plan
WASHINGTON--(BUSINESS WIRE)--RxAnte, Inc., a leading solution provider for improving medication use and drug therapy outcomes for health plans and providers, announced today a partnership with Geisinger . . .
Posted on 2/5/19
AmeriHealth Caritas Awarded Contract to Serve North Carolina’s Medicaid Population
PHILADELPHIA--(BUSINESS WIRE)--AmeriHealth Caritas, a national leader in Medicaid managed care and other health care solutions for those most in need, announced today that it has been . . .
Posted on 2/5/19
AmeriHealth Caritas Awarded Contract to Serve North Carolina’s Medicaid Population
PHILADELPHIA--(BUSINESS WIRE)--AmeriHealth Caritas, a national leader in Medicaid managed care and other health care solutions for those most in need, announced today that it has been . . .
Posted on 2/4/19
The Results Are In, and It's Clear Celgene Doesn't Need Bristol-Myers Squibb
Earnings season is well under way again. Several big drugmakers have already reported their latest quarterly results. Two companies that I was particularly interested in were . . .
Posted on 2/4/19
Better Buy: Johnson & Johnson vs. AbbVie
Shares of Johnson & Johnson (NYSE:JNJ) have slipped around 10% since the beginning of December, and investors shopping for steady dividends are wondering if there could . . .

